Leroy Jeske
Family Medicine · Broken Arrow, OKNPI 1205839446
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $420 and has fallen 56.3% since, to $184 in 2022.
Across 78 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$140
- Amgen$125
- AbbVie$119
- Abbott$87
- Amarin Pharma, Inc.$77
- Johnson & Johnson$54
- plus $598 from 23 others
What the payments were for
- Food & beverage$1,200100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $140 |
| Amgen | 6 | $125 |
| AbbVie(2 entities) | 7 | $119 |
| Abbott | 5 | $87 |
| Amarin Pharma, Inc. | 5 | $77 |
| Johnson & Johnson | 4 | $54 |
| GSK | 3 | $44 |
| Nevro Corp. | 1 | $43 |
| AstraZeneca | 3 | $43 |
| Lilly USA, LLC | 3 | $42 |
| Boehringer Ingelheim | 3 | $42 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Bardy Diagnostics, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Pfizer | 2 | $27 |
| Alk-abello, Inc | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Althera Pharmaceuticals LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Merck | 1 | $13 |
| Eisai Inc. | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
How this compares
$1,200 in reported general payments places this provider in the 65th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Broken Arrow
- James CampbellBroken Arrow$35K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
- Michael RobinsonElk City$84K
- Kimberly HuttonTulsa$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.